Demographics (2)
- AGE_AT_CRANIOTOMY - Age at craniotomy (phv00565018.v1.p1)
- SEX - Biological sex (phv00526062.v1.p1)
Disease Events (15)
- BODY_SITE - Body site where sample was collected (phv00526068.v1.p1)
- BRAIN_METASTASES_PRESENT_AT_FIRST_DIAGNOSIS_OF_METASTATIC_DISEASE - Brain metastases present at first diagnosis of metastatic disease (phv00565022.v1.p1)
- CLINICAL_MOLECULAR_TESTING - Clinical molecular testing (phv00565023.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00526071.v1.p1)
- IS_TUMOR - Tumor status (phv00526070.v1.p1)
- LOCATION_OF_PRIMARY_MELANOMA - Location of primary melanoma (phv00565020.v1.p1)
- MELANOMA_TYPE - Melanoma type (phv00565019.v1.p1)
- MONTHS_CRANIOTOMY_TO_LAST_FOLLOWUP - Months from craniotomy to death or last follow-up (phv00565030.v1.p1)
- RADIATION_THERAPY - Radiation therapy (phv00565027.v1.p1)
- RESULTING_MOLECULAR_CHARACTERISTICS - Resulting molecular characteristics (phv00565024.v1.p1)
- STAGE_AT_DIAGNOSIS_OF_PRIMARY_MELANOMA - Stage at diagnosis of primary melanoma (phv00565021.v1.p1)
- STATUS - Patient status at the time of last follow up (phv00565029.v1.p1)
- TISSUE_TYPE - Tissue type, e.g. metastasis vs blood vs unspecified tumor (unknown if primary or metastasis) (phv00526072.v1.p1)
- TRT_AFTER_CRANIOTOMY_SYSTEMIC - Systemic therapy treatment after craniotomy (phv00565026.v1.p1)
- TRT_BEFORE_CRANIOTOMY_SYSTEMIC - Systemic therapy treatment before craniotomy (phv00565025.v1.p1)
Race and Ethnicity (1)
- RACE - Reported race (phv00526066.v2.p1)
Other (14)
- ANALYTE_TYPE - Analyte type (phv00526069.v1.p1)
- ANALYZED_IMMUNE_MICROENVIRONMENT_BY_MBM_BRAFV600_STATUS - Patient included in analysis of immune microenvironment by MBM BRAFV600 status (phv00565034.v1.p1)
- ANALYZED_SURVIVAL_BY_MBM_BRAFV600_STATUS - Patient included in analysis of survival explained by MBM BRAFV600 status (phv00565033.v1.p1)
- ANALYZED_SURVIVAL_BY_MBM_IMMUNE_MICROENVIRONMENT - Patient included in analysis of survival explained by MBM immune microenvironment (phv00565031.v1.p1)
- ANALYZED_SURVIVAL_BY_MBM_PTEN_EXPRESSION - Patient included in analysis of survival explained by MBM PTEN expression (phv00565032.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00526061.v1.p1)
- SAMPLE_ID - Sample ID (phv00526067.v1.p1)
- SAMPLE_ID - Sample ID (phv00526064.v1.p1)
- STORAGE - Storage details, e.g sample preservation/processing. (phv00526073.v1.p1)
- SUBJECT_ID - Subject ID (phv00526065.v2.p1)
- SUBJECT_ID - Subject ID (phv00526060.v1.p1)
- SUBJECT_ID - Subject ID (phv00526063.v1.p1)
- SUBJECT_ID_MANUSCRIPT - Subject ID used in Kennedy et al. 2025 manuscript (phv00565035.v1.p1)
- TIMING_CNS_RADIATION - Timing of CNS radiation (phv00565028.v1.p1)